Why the study?
Does pretreatment with a PAF antagonist ameliorate LPS-induced cardiovascular collapse and LV alterations in a rat model of endotoxemia?
Does pretreatment with a PAF antagonist ameliorate LPS-induced cardiovascular collapse and LV alterations in a rat model of endotoxemia?
Pretreatment with a platelet-activating factor antagonist attenuates endotoxin-induced hypotension and left ventricular structural and functional alterations in a rat model of endotoxemia.
No takes yet. Share an insight, caveat, or question.
Iwase et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: